ABSENCE OF POINT MUTATIONS IN A FUNCTIONALLY IMPORTANT PART OF THE EXTRACELLULAR DOMAIN OF THE C-KIT PROTOONCOGENE IN A SERIES OF PATIENTS WITH ACUTE MYELOID-LEUKEMIA (AML)

被引:0
|
作者
ARLAND, M [1 ]
FIEDLER, W [1 ]
SAMALECOS, A [1 ]
HOSSFELD, DK [1 ]
机构
[1] UNIV HAMBURG,HOSP EPPENDORF,DEPT HEMATOL ONCOL,D-20246 HAMBURG,GERMANY
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The proto-oncogenes c-fms and c-kit belong to a family of growth factor receptors possessing protein kinase activity. It has been shown that transfection of a c-fms gene carrying a point mutation at codon 301, leads to a ligand-independent transformation of mouse NIH3T3 cells. In human acute myeloid leukemia (AML), point mutations at codon 301 of the c-fms gene have been observed implying an important role in the transformation process. The possibility of a point mutation of the c-kit proto-oncogene was investigated. We sequenced a segment of the c-kit proto-oncogene coding for a part of the extracellular domain. This segment was 40.7% homologous to the c-fms region encompassing codon 301. c-DNA was prepared from peripheral blood or bone marrow cells from 25 patients with AML, from four patients with myelodysplastic syndrome (MDS) and from three human myeloid cell lines. The region of interest was amplified with two rounds of polymerase chain reactions (PCR) with nested primers and directly sequenced. No point mutations were found in the investigated samples. Thus, point mutations in this segment of the c-kit gene do not seem to play an important role in the transformation process of human acute leukemia.
引用
收藏
页码:498 / 501
页数:4
相关论文
共 50 条
  • [1] ABSENCE OF POINT MUTATIONS IN THE EXTRACELLULAR DOMAIN OF THE A SUBUNIT OF THE GM-CSF RECEPTOR IN A SERIES OF PATIENTS WITH ACUTE MYELOID-LEUKEMIA (AML)
    DECKER, J
    FIEDLER, W
    SAMALECOS, A
    HOSSFELD, DK
    LEUKEMIA, 1995, 9 (01) : 185 - 188
  • [2] Detection of C-KIT Mutations in Acute Myeloid Leukemia
    Szankasi, P.
    Ho, A. K.
    Kelley, T. W.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2009, 11 (06): : 630 - 630
  • [3] Incidence and prognostic significance of c-kit exon 8 and 17 mutations in pediatric acute myeloid leukemia (AML).
    Goemans, BF
    Zwaan, CM
    Miller, M
    Zimmermann, M
    Hahlen, K
    Reinhardt, D
    Creutzig, U
    Kaspers, GJL
    Heinrich, MC
    BLOOD, 2003, 102 (11) : 198B - 199B
  • [4] C-KIT POINT MUTATION OF EXTRACELLULAR DOMAIN IN PATIENTS WITH MYELOPROLIFERATIVE DISORDERS
    NAKATA, Y
    KIMURA, A
    KATOH, O
    KAWAISHI, K
    HYODO, H
    ABE, K
    KURAMOTO, A
    SATOW, Y
    BRITISH JOURNAL OF HAEMATOLOGY, 1995, 91 (03) : 661 - 663
  • [5] Absence of c-kit point mutations in acquired aplastic anemia; Identification of a polymorphism in the kit transmembrane domain
    Paquette, RL
    Hsu, NC
    Koeffler, HP
    BLOOD, 1995, 86 (10) : 1905 - 1905
  • [6] The amount of c-kit receptor tyrosine: Kinase predicts outcome in acute myeloid leukemia (AML).
    Del Poeta, G
    Venditti, A
    Maurillo, L
    Buccisano, F
    Abruzzese, E
    Tamburini, A
    Suppo, G
    Del Principe, MI
    Scornajenghi, KA
    Bruno, A
    Cox, MC
    Masi, M
    Amadori, S
    BLOOD, 2001, 98 (11) : 716A - 716A
  • [7] Expression of c-kit receptor CD 117 in acute myeloid leukemia (AML) cells.
    Threja, R
    Venugopal, P
    George, S
    Coon, J
    BLOOD, 2002, 100 (11) : 255B - 255B
  • [8] The Prognostic Significance of c-KIT Mutations in Core Binding Factor Acute Myeloid Leukemia
    Shafik, Nevine F.
    Ibraheem, Dalia
    Selim, Marwa Mahmoud
    Allam, Rasha Mahmoud
    Fathalla, Lamiaa A.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (06): : E363 - E375
  • [9] Prognostic impact of c-KIT mutations in core binding factor acute myeloid leukemia
    Park, Sang Hyuk
    Chi, Hyun-Sook
    Min, Sook-Kyung
    Park, Borae G.
    Jang, Seongsoo
    Park, Chan-Jeoung
    LEUKEMIA RESEARCH, 2011, 35 (10) : 1376 - 1383
  • [10] C-FMS POINT MUTATIONS IN ACUTE MYELOID-LEUKEMIA - FACT OR FICTION
    SPRINGALL, F
    OMARA, S
    YI, SN
    TODD, A
    FORD, D
    ILAND, H
    LEUKEMIA, 1993, 7 (07) : 978 - 985